Cargando…
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination
BACKGROUND: FTY720 (fingolimod) is the first oral drug approved by the Food and Drug Administration for treatment of patients with the relapsing-remitting form of the human demyelinating disease multiple sclerosis. Evidence suggests that the therapeutic benefit of FTY720 occurs by preventing the egr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148542/ https://www.ncbi.nlm.nih.gov/pubmed/25138356 http://dx.doi.org/10.1186/s12974-014-0138-y |